Fleroxacin (Ro 23-6240): activity in virtro against 355 enteropathogenic and non-fermentative Gram-negative bacilli and Legionella pneumophila
- 1 September 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 20 (3) , 373-378
- https://doi.org/10.1093/jac/20.3.373
Abstract
The antibacterial activity of fleroxacin (Ro 23-6240, AM-833), a new 6-fluoroquinolone, was determined against 149 strains of enteropathogenic bacteria (17 species) and 191 strains (28 species) of glucose non-fermentative Gram-negative rods (excluding Pseudomonas aeruginosa), and against 15 strains of Legionella pneumophila. The cumulative susceptibility of these groups of bacteria to Ro 23-6240 at the 2 mg/l level were 99.2% 80.1 and 100% of tested strains, respectively.Keywords
This publication has 9 references indexed in Scilit:
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- Comparativein-vitro activity of ciprofloxacin against non-fermentersJournal of Antimicrobial Chemotherapy, 1985
- Uptake of ciprofloxacin by macrophages.Journal of Clinical Pathology, 1985
- The QuinolonesAnnals of Internal Medicine, 1985
- An Outbreak of Yersinia pseudotuberculosis InfectionThe Journal of Infectious Diseases, 1984
- Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogensAntimicrobial Agents and Chemotherapy, 1983
- Enteritis durch »atypische« YersinienDeutsche Medizinische Wochenschrift (1946), 1981
- Susceptibility of Legionella pneumophila to twenty antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1980